ZVRAZevra Therapeutics, Inc.

$559M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$9M

Net Income

-$5M

EPS (Diluted)

$-3.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$27M

Total Liabilities

$93M

Stockholders' Equity

-$67M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$9M	-$8M	-13.7%
Net Income	-$5M	-$11M	+50.9%

ZVRA Q4 2018 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena